Maybe one in 9 people – or 15 percent of the people using opioids -- do well long-term because of their pain issue, says Dr. David Tauben, head of the Center for Pain Relief at UW Medicine. Tauben...
(Download video) Dr. Anne-Marie E. Amies Oelschlager discusses funding cuts proposed by the U.S. Department of Health and Human Services that would affect 81 organizations nationwide that provide...
(Downloadable video soundbites and lab b-roll) Scientist David Baker discusses creating proteins custom tailored to specific therapeutic targets. See related story.
Heather Tick, a professor of anesthesiology and pain medicine at the University of Washington School of Medicine, is the lead author of a consortium pain task force white paper calling for a reform...
Type: Upload file
Artist impression of designed mini-protein binders targeting Influenza hemagglutinin to effectively bind and neutralize the virus.
When babies transition from the womb to the world, they pick up a population of beneficial bacteria, or microbiome, from their mother’s birth canal that would enhance protections from disease. But in...
It's still flu season, and Washington state is also now facing a measles outbreak. Kristina Adams Waldorf, professor of obstetrics and gynecology at the University of Washington School of Medicine,...
It's the question many ask: Is there a safe amount to drink during pregnancy? A new study published in Advances in Pediatric Research suggests the answer is no. Susan Astley Hemingway, professor of...
Many researchers realize that mice and rats are social and chatty. They spend all day talking to each other, but what are they really saying? Not only are many rodent vocalizations unable to be...
The Institute for Protein Design will become an innovation hub for new therapeutics for a variety of common, serious diseases. It will also engineer new nanomaterials for industry. Through computer...